Also, it has been indicated that CD44s playsa critical role in the TGF-β-mediated mesenchymal phenotype and is associated withpoor prognosis of HCC patients25 and also that THY1 and CD44 act as a potential biomarker for HCC34. The gene discussed is THY1; the disease is hepatocellular carcinoma.